Fewer Deaths in Hospitalized COVID Diabetes Patients on Sitagliptin Fewer Deaths in Hospitalized COVID Diabetes Patients on Sitagliptin

An observational, retrospective analysis of 338 patients with type 2 diabetes hospitalized for COVID-19 showed substantially less mortality among sitagliptin recipients compared with those on insulin.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news